Schroder Investment Management Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-249,107
| Closed | -$17M | – | 1349 |
|
|
2022
Q3 | $17M | Buy |
249,107
+6,965
| +3% | +$474K | 0.03% | 488 |
|
|
2022
Q2 | $7.74M | Sell |
242,142
-25,340
| -9% | -$810K | 0.01% | 703 |
|
|
2022
Q1 | $9.35M | Buy |
267,482
+106,136
| +66% | +$3.71M | 0.01% | 680 |
|
|
2021
Q4 | $4.72M | Buy |
161,346
+58,208
| +56% | +$1.7M | 0.01% | 772 |
|
|
2021
Q3 | $2.63M | Buy |
103,138
+17,833
| +21% | +$454K | ﹤0.01% | 917 |
|
|
2021
Q2 | $2.99M | Buy |
85,305
+35,040
| +70% | +$1.23M | ﹤0.01% | 940 |
|
|
2021
Q1 | $2.05M | Buy |
50,265
+8,069
| +19% | +$329K | ﹤0.01% | 1014 |
|
|
2020
Q4 | $1.83M | Sell |
42,196
-40,225
| -49% | -$1.74M | ﹤0.01% | 1021 |
|
|
2020
Q3 | $4.7M | Buy |
82,421
+28,619
| +53% | +$1.63M | 0.01% | 734 |
|
|
2020
Q2 | $3.4M | Buy |
53,802
+20,360
| +61% | +$1.29M | 0.01% | 733 |
|
|
2020
Q1 | $1.92M | Buy |
33,442
+2,115
| +7% | +$121K | ﹤0.01% | 802 |
|
|
2019
Q4 | $2.49M | Hold |
31,327
| – | – | ﹤0.01% | 852 |
|
|
2019
Q3 | $1.54M | Buy |
31,327
+1,360
| +5% | +$67K | ﹤0.01% | 928 |
|
|
2019
Q2 | $1.58M | Buy |
29,967
+2,482
| +9% | +$131K | ﹤0.01% | 854 |
|
|
2019
Q1 | $1.46M | Buy |
+27,485
| New | +$1.46M | ﹤0.01% | 848 |
|